Venture Global stock price target cut to $20 at Guggenheim

Published 10/03/2025, 14:20
Venture Global stock price target cut to $20 at Guggenheim

On Monday, Guggenheim analysts lowered the price target for Venture Global (NYSE:VG) to $20.00 from the previous $27.00, while maintaining a Buy rating on the stock. The adjustment followed Venture Global’s fourth-quarter 2024 earnings report, which missed consensus estimates, and the company’s 2025 guidance, which was set below consensus expectations. According to InvestingPro data, the company currently trades at $9.23 with a market capitalization of $22.33 billion, significantly below analyst targets ranging from $12 to $25.

The analysts noted that the company’s performance in 2024 suffered due to a weakening merchant commodity market and rising costs. The lower 2025 guidance was primarily attributed to a 27% decrease in the commodity spread from their previous model to current pricing. InvestingPro analysis reveals concerning financial health metrics, with a debt-to-equity ratio of 10.29 and a weak overall financial health score, indicating significant operational challenges. Despite positive developments, such as the ahead-of-schedule pre-commissioning progress at the Plaquemines project and progress toward the Final Investment Decision (FID) for CP2, these were overshadowed by the announced capital cost inflation at Plaquemines.

The broader commodity markets have been responding to the potential easing of supply constraints in the EU, stemming from Ukraine-Russia peace talks. This is in contrast to recent data pointing to continued tightness, including the EU’s decision to maintain gas storage quotas through 2027, historically low storage levels, and the possibility of multinational coordination on long-term purchasing strategies.

On March 6, 2025, Venture Global’s shares experienced a significant drop of 36%, in contrast to a 2% decline in the S&P 500. This was attributed to a lack of liquidity and investor patience with the company’s development ramp-up. During the earnings call, management confirmed that current market curves and near-term commercial contracting terms are still favorable for the returns of development projects, particularly CP2 as it moves toward FID. Management’s long-term view is that demand will outpace supply, which is not currently reflected in forward curves.

In their commentary, Guggenheim analysts acknowledged the negative data points on development costs and risks but have adjusted their model to market conditions in the near term, while leaving long-term assumptions largely unchanged. They reiterated their Buy rating on Venture Global, with a revised price target of $20.00. The company maintains strong operational metrics with EBITDA of $2.085 billion and revenue of $4.972 billion in the last twelve months, though InvestingPro’s Fair Value analysis suggests the stock is currently overvalued despite the recent price decline.

In other recent news, Venture Global reported its fourth-quarter 2024 earnings, revealing a significant revenue decline to $1.5 billion, a decrease of 737% from the previous year. Despite this, the company saw a substantial increase in net income, reaching $871 million. This financial performance has led to adjustments in analyst outlooks, with Guggenheim and Goldman Sachs both reducing their price targets to $20, while maintaining a Buy rating. Scotiabank (TSX:BNS) also revised its price target down to $15, citing concerns over Venture Global’s first-quarter performance as a publicly traded entity and lower-than-expected EBITDA guidance for 2025. The company has been advancing its Plaquemines project ahead of schedule, although it faces challenges with capital cost inflation. Analysts from firms like Guggenheim and Goldman Sachs have noted the progress at Plaquemines and the potential benefits of increased contracting levels. Venture Global’s management remains optimistic about the long-term demand for LNG and is focused on expanding production capabilities with ongoing projects such as the CP2 and Plaquemines Phase III expansion.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.